Cigna Group (NYSE:CI) Stock Position Raised by J.W. Cole Advisors Inc.

J.W. Cole Advisors Inc. grew its stake in shares of Cigna Group (NYSE:CI - Free Report) by 113.2% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 4,237 shares of the health services provider's stock after purchasing an additional 2,250 shares during the period. J.W. Cole Advisors Inc.'s holdings in Cigna Group were worth $1,394,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in CI. Brighton Jones LLC boosted its position in shares of Cigna Group by 9.3% in the 4th quarter. Brighton Jones LLC now owns 3,736 shares of the health services provider's stock worth $1,032,000 after buying an additional 318 shares in the last quarter. Proficio Capital Partners LLC increased its stake in shares of Cigna Group by 24.5% during the 4th quarter. Proficio Capital Partners LLC now owns 864 shares of the health services provider's stock valued at $239,000 after acquiring an additional 170 shares during the last quarter. Hillsdale Investment Management Inc. increased its stake in shares of Cigna Group by 4.4% during the 4th quarter. Hillsdale Investment Management Inc. now owns 2,390 shares of the health services provider's stock valued at $660,000 after acquiring an additional 100 shares during the last quarter. LPL Financial LLC increased its position in Cigna Group by 15.7% during the 4th quarter. LPL Financial LLC now owns 181,438 shares of the health services provider's stock worth $50,102,000 after purchasing an additional 24,578 shares in the last quarter. Finally, CoreFirst Bank & Trust acquired a new stake in Cigna Group during the 4th quarter worth approximately $575,000. 86.99% of the stock is currently owned by hedge funds and other institutional investors.

Cigna Group Trading Up 1.0%

Shares of NYSE:CI traded up $2.81 during midday trading on Friday, reaching $296.74. The company had a trading volume of 716,915 shares, compared to its average volume of 1,803,513. The company has a debt-to-equity ratio of 0.65, a quick ratio of 0.72 and a current ratio of 0.72. Cigna Group has a 1-year low of $262.03 and a 1-year high of $370.83. The firm has a market cap of $79.27 billion, a price-to-earnings ratio of 16.43, a price-to-earnings-growth ratio of 0.92 and a beta of 0.44. The company has a fifty day simple moving average of $313.02 and a two-hundred day simple moving average of $311.76.

Cigna Group (NYSE:CI - Get Free Report) last announced its quarterly earnings data on Friday, May 2nd. The health services provider reported $6.74 EPS for the quarter, topping analysts' consensus estimates of $6.35 by $0.39. Cigna Group had a return on equity of 18.63% and a net margin of 1.97%. The firm had revenue of $65.45 billion during the quarter, compared to analyst estimates of $60.39 billion. During the same period last year, the company posted $6.47 EPS. The business's quarterly revenue was up 14.4% compared to the same quarter last year. Research analysts predict that Cigna Group will post 29.77 earnings per share for the current year.

Cigna Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, September 18th. Shareholders of record on Thursday, September 4th will be given a dividend of $1.51 per share. The ex-dividend date is Thursday, September 4th. This represents a $6.04 dividend on an annualized basis and a yield of 2.04%. Cigna Group's payout ratio is presently 33.44%.

Analyst Ratings Changes

A number of research firms have weighed in on CI. Wall Street Zen cut Cigna Group from a "strong-buy" rating to a "buy" rating in a report on Friday, July 18th. Barclays reiterated an "overweight" rating and set a $385.00 target price (up from $382.00) on shares of Cigna Group in a research note on Monday, June 2nd. TD Cowen upgraded Cigna Group to a "strong-buy" rating in a research note on Monday, June 23rd. Robert W. Baird dropped their target price on Cigna Group from $388.00 to $362.00 and set an "outperform" rating on the stock in a research report on Tuesday, April 15th. Finally, Morgan Stanley increased their target price on Cigna Group from $379.00 to $390.00 and gave the stock an "overweight" rating in a research report on Monday, May 5th. Two equities research analysts have rated the stock with a hold rating, seventeen have given a buy rating and two have issued a strong buy rating to the company's stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Buy" and an average price target of $380.39.

Cigna Group Company Profile

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.